Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830201 | 12583020 | 1 | I | 2012 | 20160712 | 20160722 | 20160722 | EXP | CN-BAYER-2016-137507 | BAYER | LI W; ZHOU Y; LI Q; TONG H; LU W. INTESTINAL PERFORATION DURING CHEMOTHERAPEUTIC TREATMENT OF INTRA-ABDOMINAL DESMOID TUMOR IN PATIENTS WITH GARDNER^S SYNDROME: REPORT OF TWO CASES.. WORLD J SURG ONCOL. 2016;14 (1):178 | 35.00 | YR | A | F | Y | 0.00000 | 20160722 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830201 | 12583020 | 1 | PS | DACARBAZINE. | DACARBAZINE | 1 | Intravenous (not otherwise specified) | 150 MG/M2 THROUGHOUT 4 DAYS EVERY 28 DAYS | 17575 | 150 | MG/M**2 | POWDER FOR SOLUTION FOR INFUSION | QD | ||||||
| 125830201 | 12583020 | 2 | SS | DACARBAZINE. | DACARBAZINE | 1 | 17575 | POWDER FOR SOLUTION FOR INFUSION | |||||||||||
| 125830201 | 12583020 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 20 MG/M2, THROUGHOUT 4 DAYS EVERY 28 DAYS | 0 | 20 | MG/M**2 | QD | |||||||
| 125830201 | 12583020 | 4 | SS | DOXORUBICIN | DOXORUBICIN | 1 | 0 | ||||||||||||
| 125830201 | 12583020 | 5 | SS | MELOXICAM. | MELOXICAM | 1 | 10 MG/M2, UNK | 0 | 10 | MG/M**2 | |||||||||
| 125830201 | 12583020 | 6 | SS | MELOXICAM. | MELOXICAM | 1 | 7.5 MG, BID | 0 | 7.5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125830201 | 12583020 | 1 | Adenomatous polyposis coli |
| 125830201 | 12583020 | 2 | Desmoid tumour |
| 125830201 | 12583020 | 3 | Adenomatous polyposis coli |
| 125830201 | 12583020 | 4 | Desmoid tumour |
| 125830201 | 12583020 | 5 | Desmoid tumour |
| 125830201 | 12583020 | 6 | Desmoid tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125830201 | 12583020 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125830201 | 12583020 | Intestinal perforation | |
| 125830201 | 12583020 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125830201 | 12583020 | 1 | 20121011 | 0 | ||
| 125830201 | 12583020 | 3 | 2012 | 0 | ||
| 125830201 | 12583020 | 5 | 20121011 | 0 |